Markers of Inflammation Can Predict 180-Day Mortality in Cirrhosis

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Dec. 5, 2023 -- For patients with newly diagnosed cirrhosis, markers of inflammation can predict 180-day mortality, but not liver-related admissions, according to a study published online Nov. 16 in Scientific Reports.

Thit Mynster Kronborg, from Hvidovre University Hospital in Denmark, and colleagues collected plasma samples from 149 patients with newly diagnosed cirrhosis and registered deaths and hospital admissions within 180 days to examine the possible correlation between systemic markers of inflammation with admissions and mortality. The disease courses were compared with those of a validation cohort of 86 patients with cirrhosis.

The researchers found that 20 of the 92 inflammatory markers correlated significantly with 180-day mortality, but no significant correlations were seen with liver-related admissions. Based on a variety of modalities (clinical variables, inflammatory markers, clinical scores, or combinations), the logistic regression models yielded areas under the receiver operating characteristic curve of 0.73 to 0.79 for mortality and 0.61 to 0.73 for liver-related admissions. In the validation cohort, the models performed moderately well and were able to predict mortality better than they were liver-related admissions.

"We expected markers associated with mortality and admissions to overlap due to our assumption of the correlation between increased risk of death and admissions in general," the authors write. "Surprisingly, we did not find any markers of inflammation significantly associated with liver-related admissions in the study group, nor in the validation cohort."

Several authors disclosed receiving grants from the Novo Nordisk Foundation.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-06 00:37

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords